MR Spectroscopy in Brain Infections

Neuroimaging Clinics of North America

Volumn 23, Issue 3, 2013, Pages 475-498

  Gupta, Rakesh K ^a   Jobanputra, Kamlesh J ^a   Yadav, Abhishek ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Brain; Infections; MR imaging; MR spectroscopy; Neuro infections

Indexed keywords

ACETIC ACID; ALANINE; CHOLINE; CREATINE; GLUCOSE; GLYCINE; INOSITOL; ISOLEUCINE; LACTIC ACID; LEUCINE; N ACETYLASPARTIC ACID; SUCCINIC ACID; TREHALOSE; VALINE;

ASPERGILLUS; BACTERIAL MENINGITIS; BRAIN ABSCESS; BRAIN BIOPSY; BRAIN INFECTION; BRAIN MALARIA; BRAIN METABOLISM; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CEREBRAL PHAEOHYPHOMYCOSIS; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCOSIS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; EARLY DIAGNOSIS; ECHINOCOCCOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS INFECTION; FUNGAL GRANULOMA; HEPATITIS C; HERPES SIMPLEX ENCEPHALITIS; HIV ASSOCIATED DEMENTIA; HUMAN; INTERMETHOD COMPARISON; INTRACRANIAL TUBERCULOMA; LABORATORY DIAGNOSIS; MUCORMYCOSIS; NEUROCYSTICERCOSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARAINFECTIOUS ENCEPHALOPATHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SUBACUTE SCLEROSING PANENCEPHALITIS; TOXOPLASMOSIS; TUBERCULOUS MENINGITIS; ZYGOMYCOSIS;

EID: 84881372978     PISSN: 10525149     EISSN: 15579867     Source Type: Journal    
DOI: 10.1016/j.nic.2013.03.004     Document Type: Review

References (103)

1. Britt R.H., Enzmann D.R., Yeager A.S. Neuro-pathological and computerized tomographic findings in experimental brain abscess. JNeurosurg 1981, 55:590-603.
2. Venkatesh S.K., Gupta R.K. Pyogenic infections. MR imaging and spectroscopy of central nervous system infection 2001, 57-93. Kluwer Academic/Plenum Publishers, New York. R.K. Gupta, R.B. Lufkin (Eds.).
3. Kim S.H., Chang K.H., Song I.C., et al. Brain abscess and brain tumor: discrimination with invivo H-1 MR spectroscopy. Radiology 1997, 204:239-245.
4. Sudhakar K.V., Agarwal S., Rashid M.R., et al. MRIdemonstration of haemorrhage in the wall of a brain abscess: possible implications for diagnosis and management. Neuroradiology 2001, 43:218-222.
5. Shukla-Dave A., Gupta R.K., Roy R., et al. Prospective evaluation of invivo proton MR spectroscopy in differentiation of similar appearing intracranial cystic lesions. Magn Reson Imaging 2001, 19:103-110.
6. Gupta R.K., Chang K.H. Parasitic infections. MR imaging and spectroscopy of central nervous system infection 2001, 205-239. Kluwer Academic/Plenum Publishers, New York. R.K. Gupta, R.B. Lufkin (Eds.).
7. Garg M., Gupta R.K., Husain M., et al. Etiological categorization of brain abscesses with invivo proton MR spectroscopy. Radiology 2004, 230:893-899.
8. Mishra A.M., Gupta R.K., Jaggi R.S., et al. Role of diffusion-weighted imaging and invivo proton magnetic resonance spectroscopy in the differential diagnosis of ring-enhancing intracranial cystic mass lesions. JComput Assist Tomogr 2004, 28:540-547.
9. Lai P.H., Ho J.T., Chen W.L., et al. Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. AJNR Am J Neuroradiol 2002, 23:1369-1377.
10. Lai P.H., Hsu S.S., Ding S.W., et al. Proton magnetic resonance spectroscopy and diffusion-weighted imaging in intracranial cystic mass lesions. Surg Neurol 2007, 68(Suppl 1):S25-S36.
11. Nath K., Agarwal M., Ramolla M., et al. Role of diffusion tensor imaging (DTI) and invivo proton MR spectroscopy (PMRS) in the differential diagnosis of cystic intracranial mass lesions. Magn Reson Imaging 2009, 27(2):198-206.
12. Mishra A.M., Gupta R.K., Saksena S., et al. Biological correlates of diffusivity in brain abscess. Magn Reson Med 2005, 54:878-885.
13. Zimmerman R.A., Bilaniuk L.T., Sze G. Intracranial infection. Magnetic resonance imaging of the central nervous system 1987, 235-257. Raven Press, New York. M. Brant-Zawadzki, D. Norman (Eds.).
14. Shawl S. Neurologic evaluation of patient with acute bacterial meningitis. Neurol Clin 1995, 13:549-577.
15. Tandon P.N., Pathak S.N. Tuberculosis of the central nervous system. Tropical neurology 1973, 37-62. Oxford University Press, New York. J.D. Spillane (Ed.).
16. Hopewell P.C. Overview of clinical tuberculosis. Tuberculosis: pathogenesis, protection, and control 1994, 25-46. American Society of Microbiology, Washington, DC. B.R. Bloom (Ed.).
17. Gupta R.K., Pandey R., Khan E.M., et al. Intracranial tuberculomas: MRI signal intensity correlation with histopathology and localized proton spectroscopy. Magn Reson Imaging 1993, 11:443-449.
18. Gupta R.K., Husain N., Kathuria M.K., et al. Magnetization transfer MR imaging correlation with histopathology in intracranial tuberculomas. Clin Radiol 2001, 56:656-663.
19. Gupta R. Magnetization transfer MR imaging in central nervous system infections. Indian J Radiol Imaging 2002, 12:51-58.
20. Gupta R.K., Kathuria M.K., Pradhan S. Magnetization transfer MR imaging in CNS tuberculosis. AJNR Am J Neuroradiol 1999, 20:867-875.
21. Gupta R.K., Roy R., Dev R., et al. Finger printing of Mycobacterium tuberculosis in patients with intracranial tuberculomas by using invivo, exvivo, and invitro magnetic resonance spectroscopy. Magn Reson Med 1996, 36:829-833.
22. Garg M., Gupta R.K. MR spectroscopy in intracranial infection. Clinical MR neuroimaging diffusion, perfusion and spectroscopy 2005, 380-406. Cambridge university press, Cambridge, UK. J. Gillard, A. Waldman, P. Barker (Eds.).
23. Farrar D.J., Flanigan T.P., Gordon N.M., et al. Tuberculous brain abscess in a patient with HIV infection: case report and review. Am J Med 1997, 102:297-301.
24. Gupta R.K., Vatsal D.K., Husain N., et al. Differentiation of tuberculous from pyogenic brain abscesses with invivo proton MR spectroscopy and magnetization transfer MR imaging. AJNR Am J Neuroradiol 2001, 22:1503-1509.
25. Luthra G., Parihar A., Nath K., et al. Comparative evaluation of fungal, tubercular, and pyogenic brain abscesses with conventional and diffusion mr imaging and proton MR Spectroscopy. AJNR Am J Neuroradiol 2007, 28:1332-1338.
26. Gupta R.K., Prakash M., Mishra A.M., et al. Role of diffusion weighted imaging in differentiation of intracranial tuberculoma and tuberculous abscess from cysticercus granulomas-a report of more than 100 lesions. Eur J Radiol 2005, 55:384-392.
27. Reddy J.S., Mishra A.M., Behari S., et al. Role of diffusion-weighted imaging in the differential diagnosis of intracranial cystic mass lesions: a report of 147 lesions. Surg Neurol 2006, 66:246-250.
28. Kamra P., Azad R., Prasad K.N., et al. Infectious meningitis: prospective evaluation with magnetization transfer MRI. Br J Radiol 2004, 77:387-394.
29. Gupta R.K. Tuberculosis and other non-tuberculous bacterial graunulomatous infections. MR imaging and spectroscopyof central nervous system infection 2001, 95-145. Kluwer Academic/Plenum Publishers, New York. R.K. Gupta, R.B. Lufkin (Eds.).
30. Satishchandra P., Sharma G.R. Fungal infections of the nervous system. Reviews in tropical neurology 2002, 111-124. Shivam Arts, Lucknow (India). R.K. Garg, A.M. Kar, A. Agarwal (Eds.).
31. Sepkowitz K., Armstrong D. Space-occupying fungal lesions. Infections of the central nervous system 1997, 741-762. Lippincott-Raven Press, Philadelphia. W.M. Scheld, R.J. Whitley, D.T. Durack (Eds.).
32. Meyer R.D., Young L.S., Armstrong D., et al. Aspergillosis complicating neoplastic disease. Am J Med 1973, 54:6-15.
33. Kathuria M.K., Gupta R.K. Fungal infections. MR imaging and spectroscopy of central nervous system infection 2001, 177-203. Kluwer Academic/Plenum Publishers, New York. R.K. Gupta, R.B. Lufkin (Eds.).
34. Dzendrowskyi T., Himmelreich U., Malik R., et al. Distinction between cerebral Cryptococcomas, Staphylococcus aureus infections and tumours in an animal model. Proc Int Soc Mag Res Med 2000, 8:173.
35. Himmelreich U., Dzendrowoskyj T.E., Allen C., et al. Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study. Radiology 2001, 220:122-128.
36. Siegal J.A., Cacayorin E.D., Nassif A.S., et al. Cerebralmucormycosis: proton MR spectroscopy andMR imaging. Magn Reson Imaging 2000, 18:915-920.
37. Andreula C.F., Burdi N., Carella A. CNS cryptococcosis in AIDS: spectrum of MR findings. JComput Assist Tomogr 1993, 13:1477-1486.
38. Bowen B.C., Post M.J.D. Intra cranial infections. Magnetic resonance imaging of the brain and spine 1991, 501-538. Raven Press, New York. S.W. Atlas (Ed.).
39. Tien R.D., Chu P.K., Hesselink J.R., et al. Intracranial cryptococcosis in immunocompromised patients: CT and MR findings in 29 cases. AJNR Am J Neuroradiol 1991, 12(2):283-289.
40. Chang L., Miller B.L., McBride D., et al. Brain lesions in patients with AIDS: H-1 MR spectroscopy. Radiology 1995, 197(2):525-531.
41. Hauck E.F., McGinnis M., Nauta H.J. Cerebral phaeohyphomycosis mimics high-grade astrocytoma. JClin Neurosci 2008, 15:1061-1066.
42. Garg R.K., Kar A.M. Neurocysticercosis: diagnosis and treatment in special situations. Taenia solium cysticercosis from basic to clinical science 2002, 281-287. CAB International, New York. G. Singh, S. Prabhakar (Eds.).
43. Garcia H.H., Gilman R.H., Catacora M., et al. Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Cysticercosis working group in Peru. JInfect Dis 1997, 175:486-489.
44. Sharda D., Chawla S., Gupta R.K. Imaging and spectroscopy of neurocysticercosis. Taenia solium cysticercosis from basic to clinical science 2002, 311-327. CAB International, New York. G. Singh, S. Prabhakar (Eds.).
45. Chawla S., Gupta R.K., Kumar R., et al. Demonstration of scolex in calcified cysticercus lesion using gradient echo with or without corrected phase imaging and its clinical implications. Clin Radiol 2002, 57:826-834.
46. Pandit S., Lin A., Gahbauer H., et al. MR spectroscopy in neurocysticercosis. JComput Assist Tomogr 2001, 25:950-952.
47. Chawla S., Gupta R.K., Husain N., et al. Prediction of viability of neurocysticercosis with proton magnetic resonance spectroscopy and its correlation with histopathology. Life Sci 2004, 74:1081-1092.
48. Garg M., Chawla S., Prasad K.N., et al. Differentiation of hydatid cyst from cysticercus cyst by proton MR spectroscopy. NMR Biomed 2002, 15:320-326.
49. Rudman M.A., Khaffai S. CT of cerebral hydatid disease. Neuroradiology 1988, 30:496-499.
50. Önal Ç., Barlas O., Orakdögen M., et al. Three unusual cases of intracranial hydatid cyst in the pediatric age group. Pediatr Neurosurg 1997, 26:208-213.
51. Nurchi G., Floris F., Montaldo C., et al. Multiple cerebral hydatid disease: case report with magnetic resonance imaging study. Neurosurgery 1992, 30:436-438.
52. Kohli A., Gupta R.K., Poptani H., et al. Invivo protonmagnetic resonance spectroscopy in a case of intracranial hydatid cyst. Neurology 1995, 45:562-564.
53. Garg M., Gupta R.K., Prasad K.N., et al. Fertility assessment of hydatid cyst by proton MR spectroscopy. JSurg Res 2002, 106:196-201.
54. Kingsley P.B., Shah T.C., Woldenberg R. Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy. NMR Biomed 2006, 19:435-462.
55. Marsden P.D., Bruce-Chwatt I.J. Cerebral malaria. Tropics on tropical neurology 1975, 29-44. Devis, Philadelphia. R.W. Hornabrook (Ed.).
56. Sanni L.A., Rae C., Maitiland A., et al. Is ischemia involved in the pathogenesis of murine cerebral malaria?. Am J Pathol 2001, 159:1105-1111.
57. Porter S.B., Sande M.A. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. NEngl J Med 1992, 327:1643-1648.
58. Luft B.J., Hafner R., Korzun A.H., et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. NEngl J Med 1993, 329:995-1000.
59. Laissy J.P., Soyer P., Parlier C., et al. Persistent enhancement after treatment for cerebral toxoplasmosis in patients with AIDS: predictive value for subsequent recurrence. AJNR Am J Neuroradiol 1994, 115:1773-1778.
60. Issakhanian M., Chang L., Cornford M., et al. HIV-2 infection with cerebral toxoplasmosis and lymphomatoid granulomatosis. JNeuroimaging 2001, 11:212-216.
61. Revel M.P., Grey F., Brugieres P., et al. Hyperdense CT foci in treated AIDS toxoplasmosis encephalitis: MR and pathologic correlation. JComput Assist Tomogr 1992, 16:372-375.
62. Ramsey R., Gean A.D. Neuroimaging of AIDS I. Central nervous system toxoplasmosis. Neuroimaging Clin N Am 1997, 7:171-186.
63. Ionita C., Wasay M., Balos L., et al. MRI in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease. AJNR Am J Neuroradiol 2004, 25:270-273.
64. Cassady K.A., Whitley R.J. Pathogenesis and pathophysiology of viral infections of the central nervous system. Infections of the central nervous system 1997, 7-22. Lippincott-Raven Press, Philadelphia. W.M. Scheld, R.J. Whitley, D.T. Durack (Eds.).
65. Jamal M.M., Soni A., Quinn P.G., et al. Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States. Hepatology 1999, 30:1307-1311.
66. Forton D.M., Allsop J.M., Main J., et al. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001, 358:38-39.
67. Agnello V., De Rosa F.G. Extrahepatic disease manifestations of HCV infection: some current issues. JHepatol 2004, 40:341-352.
68. Hilsabeck R.C., Perry W., Hassanein T.I. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002, 35:440-446.
69. Weissenborn K., Krause J., Bokemeyer M., et al. Hepatitis C virus infection affects the brain- evidence from psychometric studies and magneticresonance spectroscopy. JHepatol 2004, 41:845-851.
70. Dore G.J., Correll P.K., Li Y., et al. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 1999, 13:1249-1253.
71. Tozzi V., Balestra P., Bellagamba R., et al. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. JAcquir Immune Defic Syndr 2007, 45:174-182.
72. Larussa D., Lorenzini P., Cingolani A., et al. Highly active antiretroviral therapy reduces the age-associated risk of dementia in a cohort of older HIV-1-infected patients. AIDS Res Hum Retroviruses 2006, 22:386-392.
73. Thein H.H., Maruff P., Krahn M.D., et al. Improved cognitive function as a consequence of hepatitis C virus treatment. HIV Med 2007, 8:520-528.
74. Navia B.A., Cho E.S., Petito C.K., et al. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986, 19:525-535.
75. Tien R.D., Felsberg G.J., Osumi A.K. Herpesvirus infections of the CNS: MR findings. Am J Roentgenol 1993, 161:167-176.
76. Lakeman F.D., Whitley R.J. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. JInfect Dis 1995, 171:857-863.
77. Morawetz R.B., Whitley R.J., Murphy D.M. Experience with brain biopsy for suspected herpes encephalitis: review of forty consecutive cases. Neurosurgery 1983, 12:654-657.
78. Gupta R.K., Lufkin R.B. Viral infections. MR Imaging and spectroscopyof central nervous system infection 2001, 147-175. Kluwer Academic/Plenum Publishers, New York. R.K. Gupta, R.B. Lufkin (Eds.).
79. Tsuchiya K., Katase S., Yoshino A., et al. Diffusion-weighted MR imaging of encephalitis. Am J Roentgenol 1999, 173:1097-1099.
80. Demaerel P., Wilms G., Robberecht W., et al. MRI and herpes simplex encephalitis. Neuroradiology 1992, 32:490-493.
81. Samann P.G., Schiegel J., Muller G., et al. Serialproton MR spectroscopy and diffusion imaging findings in HIV-related herpes simplex encephalopathy. AJNR Am J Neuroradiol 2003, 24:2015-2019.
82. Takanashi J., Sugita K., Ishii M., et al. Longitudinal MR imaging and proton MR spectroscopy in herpes simplex encephalitis. JNeurol Sci 1997, 149:99-102.
83. Silverstein A., Steinberg G., Nathanson M. Nervous system involvement in infectious mononucleosis: the heralding and-or major manifestation. Arch Neurol 1972, 26:353-358.
84. Ross J.P., Cohen J.I. Epstein-Barr virus. Infections of the central nervous system 1997, 117-127. Lippincott-Raven Press, Philadelphia. W.M. Scheld, R.J. Whitley, D.T. Durack (Eds.).
85. Cecil K.M., Jones B.V., Williams S., et al. CT, MRI and MRS of Epstein-Barr virus infection: case report. Neuroradiology 2000, 42:619-622.
86. Hagemann G., Mentzel H.J., Weisser H., et al. Multiple reversible MR signal changes caused by Epstein-Barr virus encephalitis. AJNR Am J Neuroradiol 2006, 27:1447-1449.
87. Parameshwaran K., Radhakrishnan K. Subacute sclerosing panencephalitis. Reviews in tropical neurology 2002, 30-40. Shivam Arts, Lucknow (India). A.M. Kar, R. Shukla, A. Agarwal (Eds.).
88. Trivedi R., Gupta R.K., Agarawal A., et al. Assessment of white matter damage in subacute sclerosing panencephalitis using quantitative diffusion tensor MR imaging. AJNR Am J Neuroradiol 2006, 27:1712-1716.
89. Salvan A.M., Confort-Gouny S., Cozzone P.J., et al. Invivo cerebral proton MRS in a case of subacute sclerosing panencephalitis. JNeurol Neurosurg Psychiatry 1999, 66:547-555.
90. Aydin K., Tatli B., Ozkan M., et al. Quantification ofneurometabolites in subacute sclerosing panencephalitis by 1H-MRS. Neurology 2006, 67:911-913.
91. Sidtis J.J., Price R.W. Early HIV-1 infection and theAIDS dementia complex. Neurology 1990, 40:323-326.
92. Trotot P.M., Gray F. Neuroimaging of AIDS I. Diagnostic imaging contribution in the early stages of HIV infection of the brain. Neuroimaging Clin N Am 1997, 7:243-260.
93. Chrysikopoulos H.S., Press G.A., Grafe M.R., et al. Encephalitis caused by human immunodeficiency virus: CT and MR imaging manifestations with clinical and pathologic correlation. Radiology 1990, 175:185-191.
94. Post M.J., Tate L.G., Quencer R.M., et al. CT, MR, and pathology in HIV encephalitis and meningitis. AJR Am J Roentgenol 1988, 151:373-380.
95. Heyes M.P., Ellis R.J., Ryan L., HNRC Group.HIV Neurobehavioral Research Center, et al. Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection. Brain 2001, 124:1033-1042.
96. Hawkins C.P., McLaughlin J.E., Kendall B.E., et al. Pathological findings correlated with MRI in HIV infection. Neuroradiology 1993, 35:264-268.
97. Navia B.A., Gonzalez R.G. Functional imaging of the AIDS dementia complex and the metabolic pathology of the HIV-1 infected brain. Neuroimaging Clin N Am 1997, 7:431-445.
98. Chang L., Ernst T., Leonido-Yee M., et al. Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia. Neurology 1999, 53:782-789.
99. Simone I.L., Federico F., Tortorella C., et al. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. JNeurol Neurosurg Psychiatry 1998, 64:516-523.
100. Harada M., Hisaoka S., Mori K., et al. Difference in water diffusion and lactate production in two different types of postinfectious encephalopathy. JMagn Reson Imaging 2000, 11:559-563.
101. Caldemeyer K.S., Smith R.R., Harris T.M., et al. MRI in acute disseminated encephalomyelitis. Neuroradiology 1994, 36:216-220.
102. Balasubramanya K.S., Kovoor J.M.E., Jayakumar P.N., et al. Diffusion-weighted imaging and proton MR spectroscopy in the characterization of acute disseminated encephalomyelitis. Neuroradiology 2007, 49:177-183.
103. Goo H.W., Choi C.G., Yoon C.H., et al. Acute necrotizing encephalopathy: diffusion MR imaging and localized proton MR spectroscopic findings in two infants. Korean J Radiol 2003, 4:61-65.